These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 24242212

  • 1. The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
    Rothe A, Jachimowicz RD, Borchmann S, Madlener M, Keßler J, Reiners KS, Sauer M, Hansen HP, Ullrich RT, Chatterjee S, Borchmann P, Yazaki P, Koslowsky TC, Engert A, Heukamp LC, Hallek M, von Strandmann EP.
    Int J Cancer; 2014 Jun 15; 134(12):2829-40. PubMed ID: 24242212
    [Abstract] [Full Text] [Related]

  • 2. Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma.
    Jachimowicz RD, Fracasso G, Yazaki PJ, Power BE, Borchmann P, Engert A, Hansen HP, Reiners KS, Marie M, von Strandmann EP, Rothe A.
    Mol Cancer Ther; 2011 Jun 15; 10(6):1036-45. PubMed ID: 21525185
    [Abstract] [Full Text] [Related]

  • 3. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T, Sun F, Xie W, Tang M, He H, Jia X, Tian X, Wang M, Zhang J.
    Cancer Lett; 2016 Mar 28; 372(2):166-78. PubMed ID: 26791237
    [Abstract] [Full Text] [Related]

  • 4. A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo.
    von Strandmann EP, Hansen HP, Reiners KS, Schnell R, Borchmann P, Merkert S, Simhadri VR, Draube A, Reiser M, Purr I, Hallek M, Engert A.
    Blood; 2006 Mar 01; 107(5):1955-62. PubMed ID: 16210338
    [Abstract] [Full Text] [Related]

  • 5. CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.
    Peipp M, Wesch D, Oberg HH, Lutz S, Muskulus A, van de Winkel JGJ, Parren PWHI, Burger R, Humpe A, Kabelitz D, Gramatzki M, Kellner C.
    Scand J Immunol; 2017 Oct 01; 86(4):196-206. PubMed ID: 28708284
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S, Denman CJ, Cobanoglu ZS, Kiany S, Lau CC, Gottschalk SM, Hughes DP, Kleinerman ES, Lee DA.
    Pharm Res; 2015 Mar 01; 32(3):779-92. PubMed ID: 24203492
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with a fusion protein of the extracellular domains of NKG2D to IL-15 retards colon cancer growth in mice.
    Xia Y, Chen B, Shao X, Xiao W, Qian L, Ding Y, Ji M, Gong W.
    J Immunother; 2014 Jun 01; 37(5):257-66. PubMed ID: 24810637
    [Abstract] [Full Text] [Related]

  • 11. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
    Jiang B, Wu X, Li XN, Yang X, Zhou Y, Yan H, Wei AH, Yan W.
    Cell Immunol; 2014 Jul 01; 290(1):10-20. PubMed ID: 24859012
    [Abstract] [Full Text] [Related]

  • 12. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A.
    Cancer Res; 2011 Sep 15; 71(18):5998-6009. PubMed ID: 21764762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.
    Heinemann A, Zhao F, Pechlivanis S, Eberle J, Steinle A, Diederichs S, Schadendorf D, Paschen A.
    Cancer Res; 2012 Jan 15; 72(2):460-71. PubMed ID: 22102694
    [Abstract] [Full Text] [Related]

  • 15. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M, Hachimine K, Huang J, Shibaguchi H, Kinugasa T, Maekawa S, Kuroki M.
    Anticancer Res; 2005 Jan 15; 25(6A):3725-32. PubMed ID: 16302732
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.
    Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914
    [Abstract] [Full Text] [Related]

  • 18. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.
    Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A.
    Clin Cancer Res; 2014 Nov 15; 20(22):5733-44. PubMed ID: 25212604
    [Abstract] [Full Text] [Related]

  • 19. Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity.
    Kellner C, Hallack D, Glorius P, Staudinger M, Mohseni Nodehi S, de Weers M, van de Winkel JG, Parren PW, Stauch M, Valerius T, Repp R, Humpe A, Gramatzki M, Peipp M.
    Leukemia; 2012 Apr 15; 26(4):830-4. PubMed ID: 22005785
    [No Abstract] [Full Text] [Related]

  • 20. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
    Molfetta R, Quatrini L, Capuano C, Gasparrini F, Zitti B, Zingoni A, Galandrini R, Santoni A, Paolini R.
    Eur J Immunol; 2014 Sep 15; 44(9):2761-70. PubMed ID: 24846123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.